^
Association details:
Biomarker:No biomarker
Cancer:Esophageal Cancer
Drug:paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Preferred regimens…paclitaxel.